BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 220469)

  • 1. Human carcinoma-associated precursor antigens of the NM blood group system.
    Springer GF; Desai PR; Murthy MS; Scanlon EF
    J Surg Oncol; 1979; 11(2):95-106. PubMed ID: 220469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen.
    Springer GF; Murthy MS; Desai PR; Scanlon EF
    Cancer; 1980 Jun; 45(12):2949-54. PubMed ID: 6248184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them.
    Springer GF; Desai PR; Scanlon EF
    Cancer; 1976 Jan; 37(1):169-76. PubMed ID: 55297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.
    Springer GF; Desai PR; Banatwala I
    J Natl Cancer Inst; 1975 Feb; 54(2):335-9. PubMed ID: 163330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type skin hypersensitivity reaction (DTH) to Thomsen-Friedenreich (T) antigen as diagnostic test for human breast adenocarcinoma.
    Springer GF; Desai PR; Murthy MS; Scanlon EF
    Klin Wochenschr; 1979 Sep; 57(18):961-3. PubMed ID: 228112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma-associated cytostructural antigenic alterations: detection by lectin binding.
    Howard DR; Ferguson P; Batsakis JG
    Cancer; 1981 Jun; 47(12):2872-7. PubMed ID: 6167345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera.
    Springer GF; Taylor CR; Howard DR; Tegtmeyer H; Desai PR; Murthy SM; Felder B; Scanlon EF
    Cancer; 1985 Feb; 55(3):561-9. PubMed ID: 2981150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma-associated blood group MN precursor antigens against which all humans possess antibodies.
    Springer GF; Desai PR; Yang HJ; Murthy MS
    Clin Immunol Immunopathol; 1977 May; 7(3):426-41. PubMed ID: 68842
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.
    Springer GF; Murthy SM; Desai PR; Fry WA; Tegtmeyer H; Scanlon EF
    Klin Wochenschr; 1982 Feb; 60(3):121-31. PubMed ID: 6176752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-antigen does not induce cell mediated immunity in patients with breast cancer.
    Howard DR
    Cancer; 1983 Jun; 51(11):2053-6. PubMed ID: 6839295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma.
    Wang BL; Springer GF; Carlstedt SC
    J Histochem Cytochem; 1997 Oct; 45(10):1393-400. PubMed ID: 9313800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas.
    Otsuka K; Kudo T; Nakajima T; Ohkuma S
    Int J Biochem; 1991; 23(5-6):569-78. PubMed ID: 1648519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.
    Springer GF
    J Mol Med (Berl); 1997 Aug; 75(8):594-602. PubMed ID: 9297627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
    Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
    J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells.
    Howard DR; Taylor CR
    Oncology; 1980; 37(3):142-8. PubMed ID: 6244524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies.
    Zanetti M; Lenert G; Springer GF
    Int Immunol; 1993 Feb; 5(2):113-9. PubMed ID: 7680895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewis blood group antigens (a and b) in human breast tissues. Loss of Lewis-b in breast cancer cells and correlation with tumor grade.
    Idikio HA; Manickavel V
    Cancer; 1991 Sep; 68(6):1303-8. PubMed ID: 1651804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma.
    Tomana M; Kajdos AH; Niedermeier W; Durkin WJ; Mestecky J
    Cancer; 1981 Jun; 47(11):2696-703. PubMed ID: 6266639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen.
    Seitz RC; Fischer K; Stegner HE; Poschmann A
    Cancer; 1984 Sep; 54(5):830-6. PubMed ID: 6331628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them.
    Springer GF; Desai PR; Murthy MS; Tegtmeyer H; Scanlon EF
    Prog Allergy; 1979; 26():42-96. PubMed ID: 386359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.